Oseltamivir phosphate—Lifting the restriction on its use to treat teenagers with influenza in Japan-Reference-Cited by-同舟云学术

Oseltamivir phosphate—Lifting the restriction on its use to treat teenagers with influenza in Japan

Published:2019-03-04 Issue:4 Volume:28 Page:434-436
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Takeuchi Satoshi¹,Tetsuhashi Masashi¹,Sato Daisaku²^ORCID

Affiliation:

1. Pharmaceutical Safety Division, Ministry of Health, Labour and Welfare Japan

2. Center for Regulatory SciencePharmaceuticals and Medical Devices Agency Japan

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4721

Reference20 articles.

1. Notification of Dear health professional letter on oseltamivir phosphate.Ministry of Health Labour and Welfare (MHLW).2007[cited: available fromhttps://www.mhlw.go.jp/houdou/2007/03/h0320‐1.html

2. Estimated shares of anti‐influenza drugs.The Drug Safety Subcommittee MHLW.2010[cited: available fromhttps://www.mhlw.go.jp/stf2/shingi2/2r9852000000n6tv‐att/2r9852000000n7ph.pdf

3. Estimated shares of anti‐influenza drugs.The Drug Safety Subcommittee MHLW.2017[cited: available fromhttps://www.mhlw.go.jp/file/05‐Shingikai‐11121000‐Iyakushokuhinkyoku‐Soumuka/0000183976.pdf

4. Fatal case reports of abnormal behaviors after taking anti‐influenza drugs. MHLW Press release.2017[cited: available fromhttps://www.mhlw.go.jp/file/04‐Houdouhappyou‐11125000‐Iyakushokuhinkyoku‐Anzentaisakuka/0000185995.pdf

5. Severe abnormal behavior incidence after administration of neuraminidase inhibitors using the national database of medical claims

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for Prevention and Control of Influenza in Children, 2024–2025: Technical Report;Pediatrics;2024-08-26

2. Recommendations for Prevention and Control of Influenza in Children, 2023–2024;Pediatrics;2023-08-29

3. Recommendations for Prevention and Control of Influenza in Children, 2022–2023;Pediatrics;2022-09-06

4. The use of antiviral drugs in children;Journal of Chemotherapy;2021-10-11

5. Recommendations for Prevention and Control of Influenza in Children, 2021–2022;Pediatrics;2021-10-01